Crossmark

Case report of Guillain-Barré Syndrome after COVID BNT162b2 mRNA vaccine

Crossref DOI link: https://doi.org/10.1016/j.vacune.2022.05.004

Published Print: 2022-08

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Sosa-Hernández, Oscar

Sánchez-Cardoza, Sofía
License Information

Text and Data Mining valid from 2022-08-01

stm-asf valid from 2022-08-01

stm-asf valid from 2022-08-01

stm-asf valid from 2022-08-01

stm-asf valid from 2022-08-01

stm-asf valid from 2022-08-01
More Information

This article is maintained by: Elsevier

Article Title: Case report of Guillain-Barré Syndrome after COVID BNT162b2 mRNA vaccine

Journal Title: Vacunas (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.vacune.2022.05.004

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.vacun.2022.02.002

Content Type: article

Copyright: © 2022 Published by Elsevier España, S.L.U.